HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Top Medical News

Renaming Monkeypox to Mpox

November 28th 2022

The World Health Organization (WHO) made the announcement today.

Rise in Pediatric COVID-19 Hospitalizations

November 28th 2022

Investigators looked at COVID-19 related hospitalizations in infants less than 6 months old who were unable to be vaccinated. The researchers used population-based surveillance for lab-confirmed COVID-19 hospitalizations.

Monoclonal Antibody Treatment for COVID-19 in Pregnant People Seems Safe

November 27th 2022

A recent study by investigators at the University of Pittsburgh School of Medicine found few mild adverse events from monoclonal antibody treatment among pregnant people with COVID-19, but no difference in COVID-19 outcomes.

C difficile Awareness Month: Breakthroughs and Setbacks

November 25th 2022

November is C difficile Awareness Month. We're recapping the most significant potential therapies and remaining challenges from the past month.

Treatment Options for Heavily Treatment-Experienced Patients with Multi-Drug Resistant HIV

November 25th 2022

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, explore the relative pros and cons of various agents and drug classes that may be used for the treatment of multi-drug resistant HIV.

Conference Coverage
View All >>

Opinions of Oral Versus Injectable HIV PrEP in a Racially Diverse Cohort

November 16th 2022

Concerns of injectable HIV PrEP safety and efficacy demonstrate a need for health care providers to share reliable information with at-risk populations.

Has HIV PrEP Uptake Increased Among High-Risk Persons?

November 15th 2022

Although HIV PrEP uptake is gradually increasing, usage remains low among key at-risk populations.

Indicators of Severe Outcomes in Chronic Hepatitis B Patients

November 14th 2022

What are the characteristics and demographics of the chronic hepatitis B patients who develop severe outcomes?

Best of IDWeek 2022

November 4th 2022

Experts discuss a range of the most topical infectious disease research, presented at the recent IDWeek 2022 conference.

Video Interviews
View All >>
Promising Phase 3 Data Suggest Efficacy of Ibrexafungerp for Vaginal Yeast Infection
Binge Drinking Increases the Risk of COVID-19 Infection
Protecting Infants, Young Children by Vaccinating Teens and Adults
Did the COVID-19 Pandemic Affect Young Women’s Substance Use? Part 1
Novel Inhibitor for Treating Hospitalized Patients With COVID-19
Health Equity and Vaccines: A Combination of Internal and External Forces Drove Low Rates
Bridging the Gap: Finding Treatments for Moderate COVID-19 Disease
Highlighting IDWeek Abstracts With Thomas Lodise, PharmD, PhD
Analyzing Remdesivir Resistance, 2 Years and Many Variants Later
Developing a System to Distinguish C Diff Colonization from Infection Within a Health System
Bolstering Influenza Vaccination in People With HIV During COVID-19
Investigational Antibiotic Data Confirms Benefit for Acinetobacter Baumannii Infections
Taking the Guesswork out of ICU Pneumonia Diagnosis
A Rapid Sepsis Diagnostic Test for Better Patient Outcomes
Assessing Antimicrobial Prescribing for FEP-Susceptible ESBL-E BSIs
Podcasts
View All >>
C difficile, Antimicrobials, and the Patients Most Affected
World Hepatitis Day: Where Do We Go From Here?
ACIP Preferentially Recommends Fluzone High-Dose Influenza Vaccine for Seniors
"A Social and Political Pandemic”: HIV Disparities in LGBTQ+ People
Forging an Evolutionary Regulatory Path for Antibiotic Development
“We Treat People With Dignity”: An Alternative Healthcare Clinic for People Who Use Drugs
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Vaccine Inequity With Dr. Leonard Friedland
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD
COVID-19 Vaccine Race: FDA Advisory Committee Meeting with Donald Alcendor, PhD